Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
One of the company's pipeline drugs is showing significant promise. Clinical-stage biotech Nektar Therapeutics (NKTR 15.06%) had some encouraging news to report from the lab…
One of the company's pipeline drugs is showing significant promise. Clinical-stage biotech Nektar Therapeutics (NKTR 15.06%) had some encouraging news to report from the lab…
Two analysts in two days became notably more bullish on its future. Chinese internet search king Baidu (BIDU 11.34%) was looking very regal on Wednesday,…
A peer across the Pacific Ocean has purchased the rights to one of the biotech's pipeline drugs. On Monday, investors clearly saw excellent value in…
A good one-week stretch is capped by a substantial analyst price target raise. According to data compiled by S&P Global Market Intelligence., AppLovin's (APP 1.87%)…
It's always encouraging to get what appears to be good news from the FDA. On a very good Friday for the stock market, Biohaven's (BHVN…
At just 12x this year's free cash flow, Zoom Communications stock could be an incredible buy. Pandemic communications star Zoom Communications (ZM 9.98%) stock, um…